BioSpace News Archive

Chubb has introduced its new Gap Supplement Medical plan – an enhanced supplemental healthcare insurance product designed to reimburse consumers for qualifying out-of-pocket expenses not reimbursed by their medical insurance plans

Dendreon Pharmaceuticals LLC, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, today announced it has signed a long-term lease agreement for its current South Lake Union location

The Alternative Energies and Atomic Energy Commision, Europe’s most innovative research center today announces it will host booth #50653 at CEA Tech Village, during CES 2019

LunaDNA LLC announced today that its securities offering has been qualified and its platform is now open to U.S. residents.

Monmouth Junction, NJ, Tris Pharma, Inc. has voluntarily recalled three (3) lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the retail level.

Chemotherapy causes chemotherapy-induced peripheral neuropathy (CIPN) in a significant number of patients, yet the pharmaceutical landscape is completely devoid of treatments to prevent CIPN.

QxMD Software Inc., a digital learning technology company that helps healthcare professionals (HCPs) to advance clinical practice with evidence-based research and decision support tools, today announced that the company had achieved a new membership milestone by exceeding the 200 million mark for annual aggregate views across the company’s HCP content engagement platform QxMD Pathways.

Health Canada considering measures to prohibit or restrict the use of talc in certain cosmetics, natural health products and non-prescription drugs

Collaboration will create compliant cannabis experiences for consumers at music festivals

Columbia research reveals importance of memory in driving key social behavior; offers insight into psychiatric disorders such as schizophrenia